Anticoagulant medication at time of needle biopsy for breast cancer in relation to risk of lymph node metastasis

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 238-241

  Ljung, Rickard ^a   Sennerstam, Roland ^a   Mattsson, Fredrik ^a   Auer, Gert ^a   Lagergren, Jesper ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

anticoagulantia; aspirin; biopsy; breast cancer; clotting; mammography; metastasis; stage; Sweden

Indexed keywords

ANTICOAGULANTIA; ASPIRIN; BIOPSY; BREAST CANCER; CLOTTING; MAMMOGRAPHY; METASTASIS; STAGE; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; BIOPSY, NEEDLE; BLOOD COAGULATION; BLOOD PLATELETS; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMOGRAPHY; MIDDLE AGED; SWEDEN;

EID: 84899436195     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28671     Document Type: Article

References (11)

1. Gay LJ, Felding-Habermann B,. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011; 11: 123-34. doi: 10.1038/nrc3004.
2. Liebens F, Carly B, Cusumano P, et al. Breast cancer seeding associated with core needle biopsies: a systematic review. Maturitas 2009; 62: 113-23.
3. Wiksell H, Schässburger KU, Janicijevic M, et al. Prevention of tumour cell dissemination in diagnostic needle procedures. Br J Cancer 2010; 103: 1706-9.
4. Sennerstam R, Schässburger KU, Stormby N, et al. Axillary lymph node metastasis and survival in breast cancer patients with concurrent cardio-cerebral-vascular disease. JRSM Short Rep 2011; 2: 12.
5. Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726e35.
6. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48: 27e33.
7. Weitoft GR, Rosén M, Ericsson O, et al. Education and drug use in Sweden- A nationwide register-based study. Pharmacoepidemiol Drug Saf 2008; 17: 1020-8.
8. Norberg M, Danielsson, M. Overweight, cardiovascular diseases and diabetes. Health in Sweden: The National Public Health Report 2012. Scand J Public Health 2012; 40 (suppl 9): 135-163.
9. Ljung R, Klint A, Holm LE,. Nationwide population-based Nordic screening mammography registers: the only key to final evaluation? Acta Radiol 2011; 52: 247.
10. Zackrisson S, Andersson I, Manjer J, et al. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004; 108: 754-60.
11. Sennerstam, RB,. During introduction of mammography screening analysis of three tumor size intervals in screened and post-screened periods clarified the short and long term efficacy of screening. J Cancer Sci Ther 2013;S 7: 006. doi: 10.4172/1948-5956.S7-006.